[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370067-105":59,"doc-detail-370067-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","brucein-d-suppresses-breast-cancer-proliferation-and-migration-via-targeting-the-faklrg1-signaling-pathway","Brucein D suppresses breast cancer proliferation and migration via targeting the FAK/LRG1 signaling pathway","","Breast cancer is a major cause of cancer-related death, and new therapies are urgently needed. This study investigates Brucein D, a natural compound from Brucea javanica, for its ability to suppress breast cancer progression through the FAK signaling axis. Using cell viability, migration, angiogenesis, mitochondrial dysfunction, and apoptosis assays, the work links Brucein D effects to increased ROS, ATP depletion, and loss of mitochondrial membrane potential. Clinical data and mechanistic RNA-seq support FAK inhibition and downstream LRG1-related pathway changes leading to apoptosis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/brucein-d-suppresses-breast-cancer-proliferation-and-migration-via-targeting-the-faklrg1-signaling-pathway/370067/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/brucein-d-suppresses-breast-cancer-proliferation-and-migration-via-targeting-the-faklrg1-signaling-pathway/370067.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main therapeutic idea tested in this study?","Question",{"text":112,"@type":113},"The study evaluates Brucein D as a small-molecule inhibitor targeting the FAK/LRG1 signaling pathway to suppress breast cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess breast cancer cell behavior?",{"text":117,"@type":113},"Cell viability and migration were measured using MTT and transwell assays, while angiogenesis effects were examined with a tube formation assay.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular mechanism links Brucein D to reduced tumor-related activity?",{"text":121,"@type":113},"Brucein D induced mitochondrial dysfunction, shown by elevated ROS, decreased ATP, and loss of mitochondrial membrane potential, which supported apoptosis induction.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370067,1790641415,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nBrucein D suppresses breast cancer proliferation and migration via targeting the FAK/LRG1 signaling pathway  \nLin Li􀀍, Haoyang Shen, Yu Qiu, Yan Chen & Weizhu Wu  \nBreast cancer (BC) is a leading cause of cancer-related mortality in women worldwide, underscoring the need for novel therapeutic strategies. Focal adhesion kinase (FAK) has emerged as a promising oncological target due to its central role in tumor progression. Bruceine D (BD), a natural compound from Brucea javanica, exhibits anti-cancer properties, but its mechanism in BC via FAK inhibition remains unclear. We conducted a comprehensive investigation using BC cell lines. Cell viability and migration were assessed by MTT and transwell assays, respectively. The tube formation assay examines the effect of BD on angiogenesis. Mitochondrial function was evaluated by measuring reactive oxygen species (ROS), ATP production, and mitochondrial membrane potential (ΔΨm) . Apoptosis was quantified via flow cytometry. RNA sequencing (RNA-seq) with pathway enrichment analysis was employed to identify FAK-associated signaling pathways, and key protein expression changes, including FAK and downstream factors, were validated by western blotting. BD significantly suppressed BC cell proliferation, migration, and angiogenesis by inducing mitochondrial dysfunction, characterized by elevated ROS levels, depleted ATP, and loss of ΔΨm. Clinical analysis confirmed FAK overexpression in BC tissues. Mechanistically, BD inhibited FAK signaling. RNA-seq further revealed that FAK inhibition modulated several downstream pathways, includingthe expression of LRG1, collectively leading to the induction of apoptosis. This study identifies BD as a potent small-molecule FAK inhibitor. Our findings delineate a FAK-centered mechanism of action for BD, supporting its further development as a promising therapeutic agent for BC.  \nKeywords Breast cancer, Brucein d, FAK, LRG1, Cell proliferation, Cell migration  \nAbbreviations  \nBC Breast Cancer  \nBD Brucein D  \nFAK Focal Adhesion Kinase  \nLRG1 Leucine-Rich Alpha-2-Glycoprotein 1  \nBreast cancer (BC) remains the most frequently diagnosed malignancy and the leading cause of cancer-related death among women worldwide. According to the latest global cancer statistics from the WHO International Agency for Research on Cancer (IARC), BC has surpassed lung cancer as the most commonly diagnosed cancer, with an estimated 2.3 million new cases and 670,000 deaths from BC occurred in 20221,2. The global BC burden shows significant geographic disparity, with incidence rates highest in developed regions like Australia/New Zealand and mortality rates highest in developing regions like Melanesia and Western Africa. This inequity is underscored by a sharp increase in the mortality-to-incidence ratio as the Human Development Index (HDI) decreases, rising from 17% in very high HDI regions to 56% in low HDI regions1. Although current treatment strategies—including surgery, chemotherapy, radiotherapy, hormone therapy, and biological therapy—have demonstrated efficacy in managing BC3, they often result in poor prognosis due to the complex etiology of BC and the development of drug resistance. In recent years, targeted therapy has gained widespread attention for its potential to overcome resistance mechanisms that cancer cells develop against conventional chemotherapy4. While such approaches have improved outcomes in several cancers, including BC, the emergence of drug  \nDepartment of Breast Surgery, Ningbo Medical Center Lihuili Hospital, Ningbo, China. 􀀍 email: [lhllilin@nbu.edu.cn](lhllilin@nbu.edu.cn)  \n[www. nature.com/scientificreports/](www. nature.com/scientificreports/)  \nresistance remains a major clinical challenge. There is thus an urgent need to identify novel therapeutic targetsand agents for more effective BC treatment.  \nFocal adhesion kinase (FAK), a non-receptor tyrosine kinase, is f","cbCaibvQqLts5mzv","https://ap.wps.com/l/cbCaibvQqLts5mzv","pdf",2533695,13,"English","# Background\n## Breast cancer burden and treatment challenges\n## FAK as an oncogenic target\n## LRG1 in cancer biology\n# Study design and methods\n## Cellular assays (viability, migration, angiogenesis)\n## Mitochondrial function and apoptosis measurements\n## RNA-seq, pathway enrichment, and validation\n# Key findings\n## Brucein D suppresses proliferation, migration, and angiogenesis\n## Mitochondrial dysfunction drives apoptosis\n## FAK signaling inhibition with downstream effects including LRG1\n# Conclusion","[{\"question\":\"What is the main therapeutic idea tested in this study?\",\"answer\":\"The study evaluates Brucein D as a small-molecule inhibitor targeting the FAK/LRG1 signaling pathway to suppress breast cancer progression.\"},{\"question\":\"How did the researchers assess breast cancer cell behavior?\",\"answer\":\"Cell viability and migration were measured using MTT and transwell assays, while angiogenesis effects were examined with a tube formation assay.\"},{\"question\":\"What cellular mechanism links Brucein D to reduced tumor-related activity?\",\"answer\":\"Brucein D induced mitochondrial dysfunction, shown by elevated ROS, decreased ATP, and loss of mitochondrial membrane potential, which supported apoptosis induction.\"}]","Brucein D suppresses breast cancer proliferation and migration via targeting the FAK/LRG1 signaling pathway | PDF",1790186567,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8933fe2412bf184ace3b03a6e57749a6.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab7614f344342577766aca2b0e0d7e6c.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e135f4fd47fc4bc2bcd0aa31428951f2.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8a3fa820a1c9cfae94d3262201f5461a.webp",980,1287]